Endovascular Today/LinkedIn
Oct 11, 2025, 18:47
Endovascular Today: SYMPHONY-PE Trial and Advances in Pulmonary Embolism Treatment
Endovascular Today shared a post on LinkedIn:
“Don’t miss an in-depth conversation on the latest evidence in pulmonary embolism treatment.
During this live webinar hosted in partnership with The PERT Consortium, Dr. Vivian Bishay, Dr. Sripal Bangalore, Dr. Sameh Sayfo, and Dr. Robert Dana Tomalty will explore results from the SYMPHONY-PE pivotal trial and discuss real-world outcomes, procedural strategies, and more.
Register here.
Sponsored by Imperative Care Vascular.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies